新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » BIOON报道 » 生物标记物能够确定患者对特定黑色素瘤药物的反应

生物标记物能够确定患者对特定黑色素瘤药物的反应

来源:生物谷 2013-10-31 21:42

2013年10月31日讯 /生物谷BIOON/ --科学家最近发现一种生物标记物可以帮助预测BRAF突变型黑色素瘤患者是否对靶向该基因的药物有抗性。这一研究有助于帮助患者寻找更理想疗法。虽然黑色素瘤有一半是由BRAF突变引起的,但不是所有病例都能通过现有的两种药物治疗。科学家通过检测一种S6蛋白磷酸化程度来表征患者对药物的敏感程度。磷酸化程度越低,药物的疗效越好。(生物谷Bioon.com)

详细英文报道:

Scientists have found a new biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF, a discovery that could help better tailor treatment therapies for patients with these cancers.

About half of melanomas harbor mutations in the BRAF gene, but not all patients with BRAF-mutant melanomas respond to the two FDA-approved drugs that target such cancers. Many patients who initially do well on the drugs eventually relapse because their tumors develop resistance to currently available BRAF-targeted drugs.

"Our study has identified decreased phosphorylation of the protein S6 after treatment with BRAF-targeted drugs as a functional biomarker that predicts sensitivity of BRAF-mutant melanomas to these drugs," Dr. Ryan Corcoran, a Damon Runyon clinical investigator and assistant professor at the Massachusetts General Hospital Cancer Center and Harvard Medical School, said in a statement.

Corcoran and colleagues found that decreased phosphorylation--the addition of a phosphate group--of the protein S6 after treatment with the melanoma drug vemurafenib boosted responsiveness of BRAF-mutant melanoma cell lines to the drug both in vitro and in mice.

The research was presented last week in Boston at the International Conference on Molecular Targets and Cancer Therapeutics hosted by the American Association for Cancer Research, the National Cancer Institute and the European Organization for Research and Treatment of Cancer.

Many of the signaling pathways that drive various types of cancer regulate phosphorylation of S6, not just the BRAF pathway, so Corcoran said the team is investigating whether S6 phosphorylation could be used as a biomarker to predict response to therapies for other cancers.

 

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库